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Introduction: Angiotensin II (Ang II) contributes to the pathological process of vascular structures, including renal
glomeruli by hemodynamic and nonhemodynamic direct effects. On renal effects, Ang II plays an important role in
the development of proteinuria and glomerulosclerosis by the modification of podocyte molecules and cell survival.
In the present study, we investigated the effect of Ang II on endoplasmic reticulum (ER) stress in podocytes.
Methods: We cultured mouse podocytes with increasing doses of Ang II and evaluated ER stress markers by
Western blotting.
Results: Ang II increased Bip protein, an ER chaperone, in a dose-dependent manner at 24 h, which was ameliorated
by losartan, an angiotensin II type 1 receptor antagonist. Ang II also increased ER stress markers, such as phospho-PERK,
phospho-eIF2α, and ATF4 proteins of podocyte, significantly in a dose-dependent manner at 24 h. Increased
phospho-PERK and ATF4 proteins were further augmented by phosphoinositide 3 (PI3)-kinase inhibitor, LY294002,
which suggested that Ang II could induce podocyte ER stress of PERK-eIF2α-ATF4 axis via PI3-kinase pathway.
Discussion: These studies suggest that Ang II could induce podocyte ER stress of PERK-eIF2α-ATF4 axis via PI3-kinase
pathway, which would contribute to the development of podocyte injury induced by Ang II, and the augmentation of
PI3-kinase would be a therapeutic target.
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Angiotensin II (Ang II) directly constricts vascular
smooth muscle cells, stimulates aldosterone production,
activates the sympathetic nervous system, and increases
sodium reabsorption, all of which are mediated through
Ang II type 1 receptor (AT1R) activation and contributes
to the development of hypertension [1,2]. In addition to
its hypertensinogenic effect, locally produced Ang II in
the kidney activates multiple signaling pathways and
mediates inflammation, renal cell growth, mitogenesis,
apoptosis, extracellular matrix accumulation, protein-
uria, and glomerulosclerosis via the angiotensin II type 1
receptor (AT1R) [3-6]. These effects of Ang II play an
important role in the pathogenesis of renal tissue injury.* Correspondence: tsha@chungbuk.ac.kr
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creativecommons.org/publicdomain/zero/1.0/The podocyte is a highly differentiated epithelial cell
that situated on the outer surface of the glomerular
basement membrane (GBM), playing a crucial role in
the regulation of glomerular filtration function, and
podocyte injury is an essential feature of proteinuria and
progressive glomerular diseases [7-9]. The foot processes
of neighboring podocytes regularly interdigitate, leaving
between them the slit diaphragm (SD), which form the
final layer of the glomerular filtration barrier and is
linked to the actin-based cytoskeleton by adaptor pro-
teins, including CD2-associated protein (CD2AP), zo-
nula occludens (ZO)-1, β-catenin, etc. [7-9].
The endoplasmic reticulum (ER) is a highly dynamic
organelle in which newly synthesized secretory and
transmembrane proteins are assembled and folded into
their correct tertiary structures, thereby, playing a
critical role in controlling the fate of cells. The ER is a
highly dynamic organelle responsible for multipledistributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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to alterations in its homeostasis. A number of condi-
tions can disturb ER functions, and these conditions
induce a state known as ER stress (ERS) [10,11].
ERS is defined as accumulation of unfolded or misfolded
proteins in the ER, which triggers an adaptive program
called the unfolded protein response (UPR) [12-14].
The adaptive UPR pathway is regulated by three major
ER-resident transducers (ERS sensors), those are RNA-
dependent pancreatic eukaryotic translation initiation
factor 2α (eIF2α) kinase (PERK, PKR-like ER kinase),
activating transcription factor 6 (ATF6), and inositol-
requiring ER-to-nucleus signal kinase 1 (IRE1). Activation
of PERK leads to phosphorylation of eukaryotic translation
initiation factor 2α (eIF2α), which causes general inhib-
ition of protein synthesis and induction of a transcription
factor ATF4 that binds to the amino acid response elem-
ent [12,13]. However, the ERS mechanisms underlying the
development of podocyte injury by Ang II remain to be
clarified. We hypothesized that PERK-eIF2α-ATF4 axis
ERS would be involved in Ang II-induced podocyte injury.
Methods
Cell culture of mouse podocytes
Conditionally immortalized mouse podocytes were kindly
provided by Peter Mundel (University of Harvard, Boston,
MA, USA) and were cultured and differentiated as de-
scribed previously [15]. Briefly, to stimulate podocyte pro-
liferation, cells were cultivated at 33°C (permissive
conditions) in a culture medium supplemented with 10 U/
mL mouse recombinant γ-interferon (Roche, Mannheim,
Germany) to induce expression of temperature-sensitive
large T antigen. To induce differentiation, podocytes were
maintained at 37°C without γ-interferon (non-permissive
conditions) for at least 2 weeks.
Treatment conditions and preparation of antibodies
Mouse podocytes were incubated with various concen-
trations of Ang II (Sigma-Aldrich Inc., St. Louis, MO,
USA) for 24 h. To inhibit phosphoinositide 3(PI3)-kinase/
Akt signaling, cells were exposed to 5 μM LY294002
(Cell Signaling Technology, Danvers, MA, USA), a PI3-
kinase inhibitor. For Ang II inhibition, losartan (Merck,
MSD LTD., Seoul, Korea) was used in a concentration
of 10−6 M for 24 h. The primary antibodies for Western
blotting were purchased as follows: anti-phospho-PERK
and anti-β-tubulin antibodies from Santa Cruz Biotech-
nology (CA, USA) and anti-Bip, anti-ATF4, anti-
phospho-eIF2α, and anti-eIF2α antibodies from Cell
Signaling (Beverly, MA, USA).
Western blotting
Total proteins from podocytes were extracted using pro-
tein extraction solution (PRO-PREP, Intron, Seongnam,Kyungki, Korea) according to the manufacturer’s instruc-
tions. Thirty micrograms of boiled extracts was applied
on 10% or 12% SDS-PAGE gels and transferred to poly-
vinylidene fluoride membranes (Bio-Rad Laboratories,
Hercules, CA, USA). Then, the membranes were air-
dried and blocked in 3% fat-free milk before incubation
with the primary antibodies. After incubation with
horseradish peroxidase-conjugated secondary antibodies
(Santa Cruz Biotechnology), bands were detected by
using the enhanced chemiluminescence system (Amersham
Biotech Ltd., Bucks, UK). In each experiment, the ratio of
absorbance of each molecule vs. β-tubulin was calculated.
Density values were expressed as percent of control
(without Ang II).
Statistical analysis
The results are expressed as mean values ± standard de-
viation. The statistical significance was assessed by non-
parametric Kruskal-Wallis ANOVA analysis or Student’s
t-test using the SPSS 9.0.0 (SPSS, Chicago, IL, USA)
software program. P values less than 0.05 were consid-
ered significant.
Results
Ang II induces ER stress in podocyte
Ang II increased Bip protein, an ER chaperone, in a
dose-dependent manner at 24 h after correcting for β-
tubulin levels (n = 3, P < 0.05 and 0.01, Figure 1A). To
assess the role of AT1R in the regulation of ER stress,
we treated cells with 10−6 M losartan. Losartan signifi-
cantly ameliorated the upregulated Bip induced by
higher does (10−7 M) of Ang II after correcting for β-
tubulin levels (n = 3, P < 0.05, Figure 1B).
Ang II upregulated ER stress proteins including
phospho-PERK, phospho-eIF2α, and ATF4 proteins in a
dose-dependent manner at 24 h after correcting for β-
tubulin levels. Ang II increased phospho-PERK signifi-
cantly in a dose-dependent manner at 24 h (n = 3, P < 0.05
and 0.01, Figure 2A). Ang II did not affect eIF2α but
increased phospho-eIF2α, which resulted that Ang II
upregulated phospho-eIF2α significantly in a dose-
dependent manner after correcting for eIF2α or β-
tubulin levels (n = 3, P < 0.05 and 0.01, Figure 2B).
Ang II also increased ATF4 significantly at high doses
at 24 h (n = 3, P < 0.05, Figure 2C).
LY294002, a PI3-kinase inhibitor, augments Ang
II-induced ER stress
Similar to Figure 1, Ang II upregulated ER stress proteins,
such as, phospho-PERK, phospho-eIF2α, and ATF4 pro-
teins in a dose-dependent manner. LY294002 further aug-
mented upregulation of phospho-PERK induced by low
doses of Ang II (n = 3, P < 0.05, Figure 3A). However,
LY294002 did not affect phospho-eIF2α upregulated by
Figure 1 Ang II induces ER stress in podocyte. Ang II increases Bip protein, an ER chaperone, in a dose-dependent manner at 24 h (A).
However, losartan significantly ameliorates the upregulated Bip induced by higher does (10−7 M) of Ang II (B). Data on the densitometric analysis
of Bip/β-tubulin ratio are expressed as mean ± SD. Control (100%); the value of without Ang II. *P < 0.05 and **P < 0.01 versus control.
Figure 2 Ang II increases ER stress proteins. Ang II increased phospho-PERK (A), phospho-eIF2α (B), and ATF4 (C) significantly in a
dose-dependent manner at 24 h. Ang II did not affect eIF2α but increased phospho-eIF2α (B). Data on the densitometric analysis of
phospho-PERK/β-tubulin ratio, phospho-eIF2α/total eIF2α ratio, and ATF4/β-tubulin ratio are expressed as mean ± SD, respectively. Control
(100%); the value of without Ang II. *P < 0.05 and **P < 0.01 versus control.
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Figure 3 LY294002, a PI3-kinase inhibitor, augments Ang II-induced ER stress. LY294002 further augments the upregulated phospho-PERK
induced by low doses of Ang II (A). However, LY294002 does not affect phospho-eIF2α upregulated by Ang II (B). LY294002 further magnified
upregulation of ATF4 induced by high doses of Ang II (C). Data on the densitometric analysis of each proteins/β-tubulin ratio are expressed as
mean ± SD (n = 3). Control (100%); the value of no Ang II conditions. *P < 0.05 and **P < 0.01 versus control. #P < 0.05 versus the respective values
without LY294002.
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regulation of ATF4 induced by high doses of Ang II (n = 3,
P < 0.05, Figure 3C). Although the response to PI3-kinase
inhibition is different to each ER stress proteins, PI3-
kinase inhibition seems to augment the upregulated ER
stress induced by Ang II.
Discussion
Dysfunction of the UPR or prolonged ERS, disturbs ER
homeostasis, leading to many human diseases, including
neurodegenerative disease, metabolic disease, inflamma-
tory disease, and diabetes mellitus [13]. It is important
to elucidate the mechanisms by which UPR signaling con-
tributes to pathogenesis of these diseases. Elucidation of the
molecular mechanisms of ERS-related diseases may shed
valuable light on these potential therapeutic targets. The in-
duction of ER stress markers has been described in human
kidney biopsies of different glomerulopathies, includingmembranous nephropathy, focal segmental glomerulo-
sclerosis, and minimal change disease [16,17]. It has been
reported that various stimuli can cause ER malfunction
leading to ERS, such as ischemia, hypoxia, hyperglycemia,
and heat shock [12-14,18]. In those stimuli, one common
obvious thing is Ang II.
It has been reported that the Ang-II plays an unprece-
dented role in the pathogenesis of STZ-induced experi-
mental diabetic nephropathy via the ERS-induced renal
apoptosis [19-21]. As the involvement of ERS in the
pathophysiology of diabetic nephropathy is relatively a
new area of research, few studies are coming out. During
the ERS, the tubular epithelial cells can undergo protective
responses, but the persistent proteinuria and hypergly-
cemia can lead to an epithelial apoptosis [20]. Sun et al.
[21] have reported that the ACE inhibitors considerably
suppressed the ER stress-induced renal tubular apoptosis
in STZ-induced experimental diabetic nephropathy model.
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specific blocker, olmesartan, blunted the upregulated
GRP78 and ER-associated apoptosis proteins, such as
TRAF2, IRE-1α, CHOP, p-JNK, and procaspase-12, in STZ-
induced diabetic mice, which suggested that Ang II inhib-
ition could be a potential therapy in treating ERS-induced
renal apoptosis via the modulation of AT-1R/CHOP-JNK-
Caspase-12 pathway in STZ-induced diabetic nephropathy.
ERS also plays an important role in podocyte injury. In
congenital nephrotic syndrome (NS) model caused by
mutational defect in CD2AP, there were dilatation of the
membrane of rough ER and increased number of cyto-
plasmic empty-appearing vacuoles, implying inadequate
protein folding ERS [22]. In another congenital NS
model caused by mutational defect in α-actinin-4, there
was upregulation of ER chaperones and ERS proteins
and increased podocyte apoptosis [23]. Mutation of the
GBM component laminin subunit β2 also leads to ex-
perimental NS, which is caused by defective secretion of
laminin from podocytes to the GBM and is accompanied
by podocyte ERS [24]. Thus, congenital NS with mutation
of the glomerular filtration components is associated with
the accumulation of mutated and misfolded proteins in
the ER and disruption of the glomerular filtration struc-
ture, leading to proteinuria [25]. These findings highlight
the possibility that UPR augmentation therapy might be
used to enhance ER proteostasis as a new therapeutic
approach to congenital NS.
ERS is the common finding under various patho-
genic microenvironments, contributing to the progres-
sion of various podocyte diseases. Abnormal protein
accumulation associated with ERS in the ER of podo-
cytes produces structural and functional damage in
the cells, which in turn leads to severe proteinuria.
Podocytes of transgenic rats overexpressing a mutant meg-
sin, without the capacity for polymerization within the ER,
do not exhibit ERS or podocyte damage, suggesting a
pathogenic role of ER retention of polymerized megsin
[26]. In another albumin overload studies, a mimic of pro-
teinuria, calcium entry via transient receptor protein 6Figure 4 Schematic view of ER stress pathway induced by Ang II in p
axis via PI3-kinase pathway. Arrows mean induction or augmentation. Ang
transcription factor 6; Bip, binding immunoglobulin protein; eIF2α, eukaryo
PKR-like ER kinase.(TRPC6) or downregulation of CD2AP by albumin over-
load induced UPR-mediated apoptosis in podocytes [22,27].
In an experimental diabetic nephropathy model, three
hallmarks of ER-associated apoptosis, C/EBP homologous
protein (CHOP), c-Jun NH2-terminal kinase (JNK), and
caspase-12, were found to have activated, suggesting that
apoptosis induced by ERS occurred in diabetic kidney,
which may contribute to the development of diabetic ne-
phropathy [28]. ERS also contributes to podocyte injury
caused by increased expression of monocyte chemo-
attractant protein 1 (MCP-1), which has a central role in
the inflammation associated with diabetic nephropathy
[29]. In experimental diabetic nephropathy and NS
models, activation of rapamycin-sensitive protein kinase
complex TORC1, which contributes to multiple cellular
processes associated with proteostasis, also triggers UPR
activation in podocytes, leading to podocyte injury [30,31].
Taken together, these findings demonstrate that not only
are mutations in podocyte protein folding associated with
ERS but acquired renal diseases that induce podocyte in-
jury are as well. Our data also demonstrated that Ang II, a
major podocyte injury inducer, could induce podocyte
ERS of PERK-eIF2α-ATF4 axis.
In podocyte, CD2AP and nephrin interact with a sub-
unit of PI3-kinase, and subsequently stimulate the PI3-
kinase-dependent activation of the intracellular Akt kinase
pathway, which is necessary for the regulation of actin dy-
namics and the cell survival [32,33]. In human cancer
cells, inhibition of lipid raft-associated PI3-kinase/PKB
(Akt) signaling by TSWU-CD4, a synthetic bichalcone
analog, induced ERS- and oligomeric Bax/Bak-mediated
apoptosis, which were substantially reversed by overex-
pression of the wt PI3-kinase p85α subunit. Therefore, the
suppression of lipid raft-associated PI3-kinase/Akt signal-
ing could induce the ERS and subsequent apoptosis [34].
In mouse pancreatic beta cells (NIT-1 cells), metformin
directly protects against dysfunction and death of ERS via
AMP-activated protein kinase (AMPK) and PI-3 kinase
activation, which were abolished by AMPK and PI3-
kinase inhibitors [35].odocyte. Ang II could induce podocyte ER stress of PERK-eIF2α-ATF4
II, angiotensin II; AT1R, angiotensin II type 1 receptor; ATF6, activating
tic translation initiation factor 2cme; ER, endoplasmic reticulum; PERK,
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pharmacological inhibition of the PI3-kinase/Akt pathway
or genetic or small interfering RNA-mediated ablation of
Akt could induce the phosphorylation of eIF2a and PERK
in mammalian cells and Drosophila cells. The activity of
PERK and the abundance of phospho-eIF2α were reduced
in mouse mammary gland tumors that contained activated
Akt, as well as in cells exposed to ERS or oxidative stress;
however, in unstressed cells, the PERK-eIF2α pathway me-
diated survival and facilitated adaptation to the deleterious
effects of the inactivation of PI3-K or Akt. Inactivation of
the PERK-eIF2α pathway increased the susceptibility of
tumor cells to death by pharmacological inhibitors of PI3-
K or Akt. Thus, they suggested that the PERK-eIF2α
pathway would provide an important link between Akt
signaling and translational control, which had implica-
tions for tumor formation and treatment. Taken to-
gether, inhibition of PI3-kinase/Akt signaling could
induce the ERS and subsequent cell death.Conclusion
In this study, PI3-kinase inhibition augmented Ang
II-induced podocyte ERS via PERK-eIF2α pathway,
which may be related to Ang II-induced podocyte
damage (Figure 4). Further study on the pathogenic
relationship between ERS and apoptosis in Ang II-
induced podocyte injury would be needed. In conclu-
sion, Ang II could induce podocyte ERS via PI3-kinase
pathway, which would contribute to the development of
podocyte injury induced by Ang II, and the augmentation
of PI3-kinase would be a novel therapeutic target of Ang
II-induced podocyte dysfunction.Competing interests
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